Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets

Purpose: To evaluate the pharmacological effects of propranolol treatment of patients with central serous chorioretinopathy (CSCR) over 4 months.<b> </b>Results: Among the 89 male and 31 female patients, the mean BCVA decreased to 0.42 ± 0.08 logMAR during CSCR attacks. Oral propranolol...

Full description

Bibliographic Details
Main Authors: Li-Chai Chen, Jui-Wen Ma, Po-Chuen Shieh, Chi-Ting Horng
Format: Article
Published: MDPI AG 2020-10-01
Online Access:https://www.mdpi.com/1424-8247/13/11/336